What Is Fiberoptic Endoscopy and How Does It Work?

Fiberoptic endoscopy transformed medicine by allowing doctors to look inside the body through a thin, flexible tube instead of relying on rigid instruments that could only reach a short distance and caused significant pain. Before the fiberscope’s development, visualizing the gastrointestinal tract meant threading stiff metal tubes down a patient’s throat, a process with severe limitations in both reach and comfort.¹ Today the term “fiberoptic endoscopy” covers a sprawling family of procedures used in gastroenterology, pulmonology, urology, and otolaryngology, though the technology itself has evolved well past the glass-fiber bundles that gave it its name.

How the Technology Works and Where It Went

The original fiberoptic endoscope transmits light and images through tightly bundled glass fibers. Each fiber carries a tiny piece of the image, and when tens of thousands of them are packed together in a coherent arrangement, the bundle can relay a recognizable picture from one end to the other. This was the breakthrough that made flexible endoscopy possible: light could travel around curves, so the instrument could bend through the esophagus, stomach, and beyond.

By the late 1980s, a new generation of instruments began replacing the fiber bundle with a miniature electronic sensor placed at the tip of the scope. These video endoscopes use a charge-coupled device (CCD) chip inside the body to convert the optical image directly into an electronic signal, which is then sent to a processor and displayed on a monitor. No fiber bundle is needed for the image at all.² The result is sharper resolution, easier documentation, and the ability for the whole clinical team to watch the procedure in real time rather than having one person peer through an eyepiece. Most endoscopy suites today use video-chip scopes, but true fiberoptic instruments remain in use for certain applications, particularly in pulmonology and otolaryngology where ultra-thin scope diameters still matter, and in settings where cost is a constraint.

Upper GI Endoscopy

The most familiar form of endoscopy for most people is esophagogastroduodenoscopy, commonly called an upper endoscopy or EGD. The scope passes through the mouth, down the esophagus, into the stomach, and into the first part of the small intestine. It is used to investigate symptoms like persistent heartburn, difficulty swallowing, unexplained abdominal pain, and vomiting blood. A large study of diagnostic EGDs in France found that the most common findings were hiatal hernia (about 18%), endoscopic gastritis (roughly 21%), and esophagitis (about 14%). Barrett’s esophagus, a precancerous change in the esophageal lining, was diagnosed in 4% of patients, while stomach ulcers appeared in about 3% and suspected malignancy in less than 1%.³

The quality of the exam depends heavily on preparation. Using agents to clear foam and mucus from the stomach lining before the scope goes in improves visibility, and adequate sedation not only makes the experience more tolerable but may also help the endoscopist spot subtle lesions. There is growing consensus that endoscopists should document the examination with standardized photographs and spend enough time inspecting each area to catch early abnormalities.⁴

Colonoscopy and the Adenoma Detection Rate

Colonoscopy is the workhorse of colorectal cancer screening. The endoscope enters through the rectum and travels the full length of the large intestine, looking for polyps, inflammation, and tumors. What makes colonoscopy unusual among screening tests is that it doubles as treatment: when a polyp is found, it can usually be removed during the same procedure. This detect-and-remove approach is why colonoscopy reduces not just cancer detection but cancer incidence itself.

One of the most important quality measures in colonoscopy is the adenoma detection rate, or ADR. This is simply the percentage of screening colonoscopies in which a doctor finds at least one adenoma (the type of polyp most likely to become cancerous). The variation between individual endoscopists is striking. A large study found that each 1% increase in an endoscopist’s ADR was linked to a 3% decrease in the risk of interval colorectal cancer, meaning cancer that appears between scheduled screenings. Patients examined by doctors in the highest detection-rate category had roughly half the risk of interval cancer compared with patients of doctors in the lowest category.⁵ A separate study reinforced the point even more starkly: people with high-risk adenomas faced more than double the risk of dying from colorectal cancer if their colonoscopy was performed by an endoscopist with a low ADR compared to one with a rate of 25% or above.⁶

The practical takeaway is that the skill and thoroughness of the person holding the scope matters enormously. Professional societies have set a minimum ADR benchmark, and endoscopists who consistently improve their detection rates show sustained reductions in their patients’ cancer risk.⁷

Airway and Lung Applications

Flexible fiberoptic bronchoscopy remains one of the areas where true fiber-bundle scopes are still widely used. The instrument is thin enough to pass through the nose or mouth, down the trachea, and into the branching airways of the lungs. It is used to evaluate persistent cough, lung infections, suspicious masses seen on imaging, and unexplained bleeding from the airways. In one large series, respiratory infections were the most common reason for bronchoscopy, accounting for nearly half of cases, followed by suspected lung cancer at about 17%.⁸

The diagnostic yield of bronchoscopy for lung nodules depends heavily on the size and location of the lesion. For masses greater than 2 cm in diameter, bronchoscopy can identify the problem in roughly 64% of cases. For smaller nodules under 2 cm, the yield drops sharply, to around 14–28% depending on where in the lung the lesion sits.⁹ Central lesions near the main airways are easier to reach and biopsy than those in the periphery of the lung.¹⁰ For very small, peripheral nodules, doctors often opt for CT-guided needle biopsy or other approaches instead.

Swallowing Assessment

A specialized application of fiberoptic endoscopy that many people do not associate with the term is FEES, or fiberoptic endoscopic evaluation of swallowing. A thin flexible scope is passed through the nose and positioned just above the larynx, where it can watch what happens when a patient swallows food and liquid. Clinicians look for food spilling into the airway before the swallow reflex triggers, residue pooling in the throat afterward, and material dropping below the vocal folds into the trachea.¹¹

FEES is often described as a first-choice method for evaluating swallowing disorders because it is portable, well tolerated, and can be done at the bedside, which matters enormously for patients who are too ill or immobile to travel to a radiology suite for a video fluoroscopy study.¹² In children with suspected swallowing difficulties, FEES can detect moderate and severe dysphagia even when a bedside clinical exam raised no alarm, making it particularly valuable for catching silent aspiration.¹³

Therapeutic Endoscopy

Endoscopy long ago outgrew its purely diagnostic origins. Through the working channels of modern scopes, clinicians can pass instruments to stop bleeding, remove tumors, place stents, and drain fluid collections. In the case of gastrointestinal bleeding, endoscopic clips and thermal coagulation devices can seal a bleeding vessel during the same procedure that identifies it. For patients with severe upper GI bleeding where standard clip therapy has failed, over-the-scope clips can serve as rescue therapy, sparing patients from more invasive interventions like embolization or surgery.¹⁴

One of the most important therapeutic endoscopic procedures is endoscopic retrograde cholangiopancreatography, or ERCP. This technique threads a special side-viewing scope into the duodenum, finds the opening of the bile and pancreatic ducts, and uses instruments to remove gallstones, place stents in blocked ducts, or take tissue samples. ERCP has evolved from a mainly diagnostic tool into a primarily therapeutic one, now most commonly performed for bile duct stones with or without infection.¹⁵ Stone clearance rates during a first ERCP session run around 90%, though the procedure carries real risks: post-procedure pancreatitis occurs in roughly 7% of patients, with bleeding and infection at lower rates.¹⁶ For patients with cancers that block the bile duct and cause jaundice, ERCP-guided stent placement can relieve the obstruction, improving liver function and quality of life even when the cancer itself is not curable.¹⁷

Endoscopic Ultrasound

Combining endoscopy with ultrasound created an entirely new diagnostic dimension. Endoscopic ultrasound, or EUS, places a small ultrasound probe at the tip of the scope, allowing the clinician to image structures immediately outside the gut wall: the pancreas, lymph nodes, bile ducts, adrenal glands, and more. When a suspicious mass is found, a fine needle can be passed through the scope and, guided by the ultrasound image, directly into the lesion to collect a tissue sample. This technique has become a cornerstone for diagnosing and staging pancreatic cancer, giving clinicians both imaging detail and tissue confirmation in one sitting.¹⁸ EUS-guided needle aspiration can also sample submucosal tumors of the GI tract, liver lesions, and even lung masses accessible through the esophageal wall.¹⁹

Reaching the Small Bowel

The small intestine was historically the blind spot of endoscopy. It sits between the stomach and the colon, but at roughly six meters long and deeply looped, it was beyond the reach of standard scopes from either end. Two innovations changed that. Capsule endoscopy uses a pill-sized camera that the patient swallows; it takes thousands of photos as it travels through the gut, transmitting them wirelessly to a recording device worn on the body. Double-balloon enteroscopy uses a scope with two inflatable balloons that alternately grip and pleat the intestine, allowing the endoscopist to inch deep into the small bowel. For detecting vascular sources of small bowel bleeding, capsule endoscopy alone has higher diagnostic accuracy, but using both methods together increases the chance of finding the bleeding source.²⁰

Sedation Choices

Most GI endoscopy involves some form of sedation. The traditional approach combines a benzodiazepine (like midazolam) with an opioid pain reliever. Propofol, a fast-acting anesthetic agent, has become an increasingly popular alternative. Meta-analyses comparing the two approaches have found that propofol does not increase the risk of low blood pressure or oxygen desaturation compared with traditional sedation.²¹ For advanced procedures like ERCP, propofol is associated with shorter recovery time, better sedation levels, and improved patient cooperation.²² One nuance worth noting: when propofol is used alone (without an added opioid), patient satisfaction may actually be slightly lower than with the traditional combination, even though the clinical safety profile is comparable.²³ In practice, many units now use propofol in combination with small doses of opioids or benzodiazepines to get the best of both worlds.

What Can Go Wrong

Diagnostic upper endoscopy is generally safe. Perforation, the most feared complication, occurs somewhere between 1 in 2,500 and 1 in 11,000 procedures. Risk factors include anatomical quirks like cervical bone spurs, Zenker’s diverticulum, and existing strictures or tumors in the upper GI tract.²⁴ Colonoscopy’s main complications are also perforation and bleeding, and the risk of both rises substantially when polyps are removed during the procedure.²⁵ Enteroscopy, the deep-small-bowel procedure, carries a somewhat higher overall complication rate, in part because of the overtube system needed to advance the scope.

The Reprocessing Problem

Endoscopes are complex, multi-channel instruments that touch mucous membranes and body fluids. Between patients, they must be meticulously cleaned, disinfected, and dried in a process called reprocessing. When reprocessing fails, the consequences can be severe. Outbreaks of carbapenem-resistant bacteria linked to contaminated duodenoscopes have been reported worldwide, raising alarm in infection control circles.²⁶ The challenge is that even following established cleaning guidelines to the letter does not always prevent contamination. Internal channels can harbor biofilm, and micro-damage like scratches inside the scope’s channels creates niches where bacteria survive disinfection.²⁷ One recent outbreak investigation found that a resistant strain of Klebsiella survived inside a brand-new replacement endoscope after reprocessing, with inspection of the dismantled scope revealing debris and scratches in the channels and the bacteria forming biofilm tolerant to the disinfectant used.²⁸

This has fueled interest in single-use (disposable) endoscopes. A meta-analysis comparing disposable to reusable scopes found that reusable instruments carried a 25% higher overall complication risk, and that fever was much less common in the disposable group.²⁹ The trade-off is cost. Every study reviewed in a systematic economic evaluation found that disposable scopes cost more per procedure. However, when quality-adjusted life years were factored in, accounting for the value of infections prevented, some analyses concluded that disposables were more cost-effective despite the higher sticker price.³⁰ Others, particularly one UK-based analysis incorporating environmental impacts, found the per-procedure cost difference so large that single-use scopes were not cost-effective at current contamination and infection rates.³¹ The debate is evolving, and different institutions are reaching different conclusions depending on their local infection rates, scope repair costs, and risk tolerance.

AI-Assisted Polyp Detection

Artificial intelligence is beginning to reshape colonoscopy. Computer-aided detection systems overlay real-time alerts on the endoscopy monitor, flagging areas the algorithm thinks contain a polyp. A meta-analysis of randomized trials found that colonoscopies performed with AI assistance detected adenomas in about 37% of patients, compared to 25% without it, a roughly 44% relative improvement.³² The gains held across polyp sizes, locations, and shapes.

There are caveats, though. Much of the improvement comes from catching very small polyps that may have had low malignant potential in the first place. The benefit for advanced adenomas and serrated lesions, which are flatter and harder to spot, is less consistent.³³ A broader systematic review covering multiple commercial AI systems found that while all of them increased overall ADR, some results lacked statistical significance, and their ability to characterize polyps (predicting whether a polyp is benign or precancerous based on its appearance) was inconsistent.³⁴ Still, the direction is clear: AI assistance is becoming a standard adjunct to colonoscopy, with the most immediate benefit likely for endoscopists whose baseline detection rates are lower.

Endoscopy Beyond the Gut

The fiberoptic endoscopy concept has spread far from its gastrointestinal origins. In urology, flexible fiberoptic ureteroscopes are used to navigate up the ureter into the kidney to break apart and remove kidney stones. A large series using single-use fiberoptic ureteroscopes achieved an overall stone-free rate above 95%, with only minor, short-lived complications like blood in the urine or temporary flank pain.³⁵ Advanced imaging modes like narrow-band imaging, which uses filtered wavelengths of light to highlight vascular patterns on the mucosal surface, allow endoscopists to distinguish dysplastic from non-dysplastic tissue in conditions like ulcerative colitis without needing to biopsy every suspicious area.³⁶

The Physical Toll on Endoscopists

An aspect of endoscopy that rarely makes it into patient-facing information is the physical cost to the practitioners themselves. Operating an endoscope involves repetitive hand and wrist movements, sustained grip on the control wheels, and awkward body postures held for extended periods. A study comparing endoscopists to non-endoscopist physicians found that 95% of endoscopists had musculoskeletal injuries, compared with about 55% of non-endoscopists. The most common sites of pain were the back, legs, and hands.³⁷ Biomechanical studies measuring the forces involved during colonoscopy found that thumb pinch force consistently exceeded established risk thresholds throughout the procedure, and wrist extensor muscle loads were highest during the insertion phase. Endoscope support devices can reduce some of the strain on the left wrist, but the fundamental ergonomic challenges of endoscope design remain largely unsolved.³⁸ Robotically assisted platforms that let the endoscopist control the scope from a seated position using joystick-style controls are in development, motivated partly by these injury rates.